Bone marrow mesenchymal stem cells autologous
CeTMMo/EM/2010
Phase 2 other completed
Quick answer
Bone marrow mesenchymal stem cells autologous for Multiple Sclerosis is a Phase 2 program (other) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Multiple Sclerosis
- Phase
- Phase 2
- Modality
- other
- Status
- completed